Back to User profile » Dr Laura Diluvio
Papers published by Dr Laura Diluvio:
The Effectiveness of a New Topical Formulation Containing GSH-C4 and Hyaluronic Acid in Seborrheic Dermatitis: Preliminary Results of an Exploratory Pilot Study
Campione E, Mazzilli S, Lanna C, Cosio T, Palumbo V, Cesaroni G, Lozzi F, Diluvio L, Bianchi L
Clinical, Cosmetic and Investigational Dermatology 2019, 12:881-885
Published Date: 16 December 2019
Omalizumab for chronic spontaneous urticaria in “complex” patients: data from real-life clinical practice
Vollono L, Piccolo A, Lanna C, Esposito M, Bavetta M, Campione E, Bianchi L, Diluvio L
Drug Design, Development and Therapy 2019, 13:3181-3186
Published Date: 6 September 2019
Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study
Mazzilli S, Garofalo V, Ventura A, Diluvio L, Milani M, Bianchi L, Campione E
Clinical, Cosmetic and Investigational Dermatology 2018, 11:485-490
Published Date: 12 October 2018
Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics
Campione E, Di Prete M, Diluvio L, Bianchi L, Orlandi A
Clinical, Cosmetic and Investigational Dermatology 2016, 9:405-409
Published Date: 7 November 2016
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors
Campione E, Paternò EJ, Candi E, Falconi M, Costanza G, Diluvio L, Terrinoni A, Bianchi L, Orlandi A
Drug Design, Development and Therapy 2015, 9:5843-5850
Published Date: 29 October 2015
Tazarotene as alternative topical treatment for onychomycosis
Campione E, Paternò EJ, Costanza G, Diluvio L, Carboni I, Marino D, Favalli C, Chimenti S, Bianchi L, Orlandi A
Drug Design, Development and Therapy 2015, 9:879-886
Published Date: 16 February 2015